Systemic corticosteroids are not effective for symptom control in patients with acute rhinosinusitis.
Patients with asthma are at higher risk of pulmonary embolism, particularly if the asthma is severe or they take oral corticosteroids.
Highest rates of adverse events seen within first month after initiating short course of oral steroids.
Patients with both asthma and allergies had a significant increase in the number of prescriptions dispensed for controller medications.
The researchers found that the median duration of cough was 5 days in both the prednisolone and placebo groups (adjusted hazard ratio, 1.11; 95% confidence interval, 0.89 to 1.39; P=0.36).
Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department.
Benralizumab has been found to be associated with a reduction in oral corticosteroid (OCS) use while maintaining asthma control for patients with OCS-dependent severe asthma.
Dermatologist, allergist, primary care doctors failed to identify etiology of rash over several months
Drugs in the Pipeline
AB Science announced the recruitment of the first patient in its Phase 3 study evaluating masitinib for severe persistent asthma.
Oral, inhaled corticosteroid use linked to increased risk for osteoporosis, fragility fractures